Back to Search
Start Over
271P First-in-human, phase I dose escalation and expansion study of anti-HER2 ADC MRG002 in patients with HER2 positive solid tumors.
- Source :
-
Annals of Oncology . 2021 Supplement 5, Vol. 32, pS480-S481. 2p. - Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 32
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152688902
- Full Text :
- https://doi.org/10.1016/j.annonc.2021.08.554